Page last updated: 2024-08-03 09:25:39

urografin 76

Description

urovision: urovision contains a mixture of sodium & meglumine salts of diatrizoic acid in the ratio of 50:18 in aqueous solution used in urography [MeSH]

Cross-References

ID SourceID
PubMed CID23667634
CHEBI ID31813
MeSH IDM0006226

Synonyms (50)

Synonym
hypaque m 380
urografin 290
verografin
hypaque-m
vascovue 76
urombrine 420
triombrast
renovist ii
angiovist 292
sodium methylglucamine diatrizoate
uropoline
triobrast
md 76
visotrast
renocal 76
verographin
radioselectan forte
renografin 60
diatrizoate de sodium et de methylglucamine [french]
uropolinum
triyosom c
urografin 325
urografin 60
sodium meglumine diatrizoate
hypaque 76
radioselectan 76
penografin-76
urografin 76
pielografin
angiovist 370
hypaque 85
urografin
hypaque 75m
trazograph
meglumine sodium amidotrizoate
8064-12-8
urovision
meglumine diatrizoate and sodium diatrizoate
meglumine sodium amidotrizoate (jp17)
D01940
md 50 (tn)
md-gastroview
renocal-76
renografin-60
diatrizoate de sodium et de methylglucamine
diatrizoate meglumine and diatrizoate sodium
md-76r
DTXSID90230450
CHEBI:31813
sodium;3,5-diacetamido-2,4,6-triiodobenzoate;3,5-diacetamido-2,4,6-triiodobenzoic acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol

Research

Studies (233)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990170 (72.96)18.7374
1990's61 (26.18)18.2507
2000's2 (0.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials37 (12.59%)5.53%
Reviews1 (0.34%)6.00%
Case Studies40 (13.61%)4.05%
Observational0 (0.00%)0.25%
Other216 (73.47%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
citric acid, anhydroustricarboxylic acidantimicrobial agent;
chelator;
food acidity regulator;
fundamental metabolite
1984198838.4low150000
lactic acid2-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
1982198540.5low120000
hydrogen carbonatecarbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1996199628.0low001000
histaminearalkylamino compound;
imidazoles
human metabolite;
mouse metabolite;
neurotransmitter
1985198837.5low220000
iodinediatomic iodinenutrient1981199735.7low121000
ureaisourea;
monocarboxylic acid amide;
one-carbon compound
Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1965199942.0low011000
1-anilino-8-naphthalenesulfonateaminonaphthalene;
naphthalenesulfonic acid
fluorescent probe1985198539.0low010000
diatrizoic acidacetamides;
benzoic acids;
organoiodine compound
environmental contaminant;
radioopaque medium;
xenobiotic
1958200637.5high2517062100
aspirinbenzoic acids;
phenyl acetates;
salicylates
anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
1984199335.5low011000
verapamilaromatic ether;
nitrile;
polyether;
tertiary amino compound
1983198341.0low010000
dantrolenehydrazone;
imidazolidine-2,4-dione
muscle relaxant;
neuroprotective agent;
ryanodine receptor antagonist
1981198143.0low010000
pentetic acidpentacarboxylic acidcopper chelator1985198539.0low010000
dipyridamolepiperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol
adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
1987198737.0low010000
erythrosine1988198836.0low010000
iodamidebenzoic acids;
organoiodine compound
radioopaque medium1985198539.0low010000
iodixanolorganoiodine compoundradioopaque medium1999199925.0low001000
iohexolbenzenedicarboxamide;
organoiodine compound
environmental contaminant;
radioopaque medium;
xenobiotic
1983200034.3low81710000
iopromidedicarboxylic acid diamide;
organoiodine compound
environmental contaminant;
nephrotoxic agent;
radioopaque medium;
xenobiotic
2000200024.0low101000
iothalamic acidorganic molecular entity1983199039.2low2101000
iotrolanorganic molecular entity1984199634.0low011000
iodipamidebenzoic acids;
organoiodine compound;
secondary carboxamide
radioopaque medium1984198539.3low030000
ioversolamidobenzoic acid1988198836.0low020000
ioxaglatebenzenedicarboxamide;
benzoic acids;
organoiodine compound
radioopaque medium1983199635.8low10136000
metoprololaromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
1990199034.0low001000
nitroglycerinnitroglycerolexplosive;
muscle relaxant;
nitric oxide donor;
prodrug;
tocolytic agent;
vasodilator agent;
xenobiotic
1981198143.0low010000
papaverinebenzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines
antispasmodic drug;
vasodilator agent
1987198737.0low020000
potassium chlorideinorganic chloride;
inorganic potassium salt;
potassium salt
fertilizer1996199628.0low001000
tolazolineimidazolesalpha-adrenergic antagonist;
antihypertensive agent;
vasodilator agent
1988198836.0low010000
phentolamineimidazoles;
phenols;
substituted aniline;
tertiary amino compound
alpha-adrenergic antagonist;
vasodilator agent
1998199826.0low001000
sorbitolglucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
1984198440.0low010000
thyroxine2-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine
antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
1984198539.5low020000
triiodothyronine2-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine
human metabolite;
mouse metabolite;
thyroid hormone
1985198539.0low010000
lysineaspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid
algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
1993199331.0low001000
sucroseglycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
1984198838.0low020000
edetic acidethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid
anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
1984198838.7low160000
mannitolmannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
1999199925.0low001000
trifluoroacetic acidfluoroalkanoic acidhuman xenobiotic metabolite;
NMR chemical shift reference compound;
reagent
1985198539.0low010000
phencyclidinebenzenes;
piperidines
anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
1984198440.0low010000
n-vinyl-2-pyrrolidinonepyrrolidin-2-ones1980198342.5low020000
diatrizoate megluminemonocarboxylic acid anionradioopaque medium1958200637.5high2517062100
megluminehexosamine;
secondary amino compound
1984198440.0low010000
iodohippuric acidbenzamides;
N-acylglycine;
organoiodine compound
1985198539.0low010000
methyl 2-cyanoacrylate1985198539.0low010000
fluorescein2-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye
fluorescent dye;
radioopaque medium
1988198836.0low010000
scandiumd-block element atom;
rare earth metal atom;
scandium group element atom
1984198440.0low010000
tantalumvanadium group element atom1984198440.0low010000
technetiummanganese group element atom1983198540.0low030000
barium sulfatebarium salt;
inorganic barium salt;
metal sulfate
radioopaque medium1985199731.3low012000
iodinehalide anion;
monoatomic iodine
human metabolite1990199531.5low002000
iopamidolbenzenedicarboxamide;
organoiodine compound;
pentol
environmental contaminant;
radioopaque medium;
xenobiotic
1983199636.2low5139000
fibrinogeniditolfungal metabolite1990199034.0low001000
acetylsalicylic acid lysinate1993199331.0low001000
meglumine iotroxinate1984198539.5low020000
technetium tc 99m pentetate1985198539.0low010000
angiotensin iiamino acid zwitterion;
angiotensin II
human metabolite1997199727.0low001000
bradykininoligopeptidehuman blood serum metabolite;
vasodilator agent
1987199633.3low021000
raffinoseraffinose family oligosaccharide;
trisaccharide
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1999199925.0low001000
metrizamideamino sugar1983198839.2low160000
meglumine iodipamideorganoammonium saltradioopaque medium1985198539.0low010000
pyrophosphatediphosphate ion1984198440.0low010000
iothalamate meglumineamidobenzoic acid1983198540.0low060000
bilirubinbiladienes;
dicarboxylic acid
antioxidant;
human metabolite;
mouse metabolite
1985198638.5low020000
technetium tc 99m pyrophosphate1984198440.0low010000
pituitrin1984198539.5low020000
atrial natriuretic factorpolypeptide1989198935.0low010000
sodium tetradecyl sulfate1985198539.0low010000
sodium pertechnetate tc 99m1986198737.5low020000
tetracycline1985198539.0low010000
sodium morrhuate1984198440.0low010000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
A-V Dissociation01988198836.0low010000
Abdominal Neoplasms01984198440.0low010000
Aberrant Tissue01983198341.0low010000
Abnormalities, Congenital01989198935.0low010000
Abnormality, Heart01964198844.5low140000
Abscess01989198935.0low010000
Absence Seizure01993199629.5low002000
Ache01983198738.8low350000
Active Hyperemia01987198737.0low010000
Acute Disease01988199035.0low011000
Acute Edematous Pancreatitis01985198539.0low010000
Acute Kidney Failure01989198935.0low010000
Acute Kidney Injury01989198935.0low010000
Adenocarcinoma01984198440.0low010000
Adenocarcinoma, Basal Cell01984198440.0low010000
Adenoma01983198738.7low030000
Adenoma, Basal Cell01983198738.7low030000
Aging01999199925.0low001000
Allergy, Drug01990199034.0low001000
Amaurosis01981199138.0low011000
Anaphylactic Reaction01984199037.7low021000
Anaphylaxis01984199037.7low021000
Anemia, Hemolytic01985198539.0low010000
Anemia, Hemolytic, Acquired01985198539.0low010000
Anemia, Sickle Cell01985198539.0low010000
Anesthesia Related Hyperthermia01981198143.0low010000
Angina Pectoris01987199533.0low011000
Angioma, Cavernous01984198440.0low010000
Angiomyxoma01984198440.0low010000
Angor Pectoris01987199533.0low011000
Anterior Choroidal Artery Infarction01977197747.0low010000
Aortic Coarctation01985198539.0low010000
Arrhythmia01980199039.0low131000
Arrhythmias, Cardiac01980199039.0low131000
Arterial Obstructive Diseases01981198342.0low120000
Arterial Occlusive Diseases01981198342.0low120000
Arteriosclerosis01992199232.0low001000
Arteriosclerosis, Coronary01991199133.0low001000
Arteriovenous Malformations, Cerebral01977197747.0low010000
Atherosclerotic Parkinsonism01993199331.0low001000
Atopic Hypersensitivity01987198737.0low010000
Benign Neoplasms, Brain01977197747.0low010000
Bilateral Headache01995199529.0low001000
Biliary Calculi01991199133.0low001000
Bladder Cancer01977198939.0low030000
Blindness01981199138.0low011000
Blood Clot01985198539.0low010000
Blood Pressure, High01984199932.5low022000
Body Weight01982198242.0low010000
Bouillaud Disease01983198341.0low010000
Bradyarrhythmia01990199034.0low001000
Bradycardia01990199034.0low001000
Brain Abscess01995199529.0low001000
Brain Diseases01996199628.0low001000
Brain Disorders01996199628.0low001000
Brain Edema01995199529.0low001000
Brain Inflammation01995199529.0low001000
Brain Neoplasms01977197747.0low010000
Brain Swelling01995199529.0low001000
Calcification, Pathologic01998199826.0low001000
Calcinosis01998199826.0low001000
Cancer of Head01982198242.0low010000
Cancer of Liver01984198440.0low010000
Cancer of Lung01984198440.0low010000
Cancer of Mediastinum01983198639.5low020000
Cancer of Parathyroid01983198738.7low030000
Cancer of Prostate01977199734.0low012000
Carcinoma, Hepatocellular01984198440.0low010000
Cardiac Cancer01984198440.0low010000
Cardiac Diseases01984199336.5low131000
Cardiac Failure01988198836.0low010000
Cardiac Hypertrophy01987198737.0low010000
Cardiomegaly01987198737.0low010000
Cardiomyopathies01983198341.0low010000
Cardiomyopathies, Primary01983198341.0low010000
Cardiovascular Diseases01993199331.0low101000
Cardiovascular Stroke01987199035.7low042000
Cerebral Infarction01977197747.0low010000
Chronic Disease01985198539.0low010000
Chronic Illness01985198539.0low010000
Chronic Kidney Failure01985199633.5low011000
Coagulation, Disseminated Intravascular01985198738.0low020000
Coarctation of Aorta01985198539.0low010000
Complication, Postoperative01985198937.0low020000
Complications of Diabetes Mellitus01993199331.0low101000
Coronary Artery Disease01991199133.0low001000
Coronary Artery Vasospasm01984198440.0low010000
Coronary Disease01981199337.9low2263000
Coronary Heart Disease01981199337.9low2263000
Coronary Thrombosis01989199333.0low012000
Coronary Vasospasm01984198440.0low010000
Cough01987198737.0low110000
Cutaneous Fistula02006200618.0low000100
Cyst01986198638.0low010000
Deafness, Sudden01985198539.0low010000
Death, Sudden01988198836.0low010000
Dehydration01986198638.0low010000
Diabetic Glomerulosclerosis01989198935.0low010000
Diabetic Nephropathies01989198935.0low010000
Disc, Herniated01984198440.0low010000
Disease Models, Animal01997199826.8low004000
Disseminated Intravascular Coagulation01985198738.0low020000
Dracunculiasis01998199826.0low001000
Drug Hypersensitivity01990199034.0low001000
Drug Overdose01993199331.0low001000
Ear Diseases02006200618.0low000100
Edema, Pulmonary01982198242.0low010000
Electrolytes01983198639.5low120000
Embolism, Pulmonary01994199430.0low001000
Emesis01995199529.0low001000
Encephalitis01995199529.0low001000
Erectile Dysfunction01997199727.0low001000
Esophageal and Gastric Varices01984198440.0low010000
Esophageal Varices01984198440.0low010000
Extravasation of Contrast Media01985198539.0low010000
Fistula02006200618.0low000100
Flaccid Quadriplegia01984198440.0low010000
Gallstones01991199133.0low001000
Gastrointestinal Hemorrhage01984198539.5low020000
Germinoblastoma01984198440.0low020000
Goldblatt Syndrome02000200024.0low101000
HbS Disease01985198539.0low010000
Head and Neck Neoplasms01982198242.0low010000
Headache01995199529.0low001000
Heart Defects, Congenital01964198844.5low140000
Heart Diseases01984199336.5low131000
Heart Failure01988198836.0low010000
Heart Valve Diseases01985198539.0low110000
Hematochezia01984198539.5low020000
Hemoglobin SC Disease01985198539.0low010000
Hepatocellular Carcinoma01984198440.0low010000
Hyperemia01987198737.0low010000
Hyperparathyroidism01983198341.0low010000
Hypertension01984199932.5low022000
Hypertension, Pulmonary01983198838.5low020000
Hypertension, Renovascular02000200024.0low101000
Hypospermatogenesis01990199034.0low001000
Icterus Gravis Neonatorum01986198638.0low010000
Impotence01997199727.0low001000
Infections, Prosthesis-Related01997199727.0low001000
Infections, Staphylococcal01997199727.0low001000
Inflammation01985198539.0low010000
Injuries, Radiation01996199628.0low001000
Innate Inflammatory Response01985198539.0low010000
Intervertebral Disc Displacement01984198440.0low010000
Intestinal Obstruction01985198539.0low010000
Intracranial Arteriovenous Malformations01977197747.0low010000
Ischemia01986198638.0low010000
Jaundice, Neonatal01986198638.0low010000
Kidney Diseases01989199929.8low013000
Kidney Failure01997199727.0low001000
Kidney Failure, Chronic01985199633.5low011000
Laryngeal Diseases01984198440.0low010000
Liver Diseases01999199925.0low101000
Liver Dysfunction01999199925.0low101000
Liver Neoplasms01984198440.0low010000
Lung Neoplasms01984198440.0low010000
Lymphoma01984198440.0low020000
Mediastinal Neoplasms01983198639.5low020000
Mitral Incompetence01990199034.0low001000
Mitral Valve Insufficiency01990199034.0low001000
Myocardial Infarction01987199035.7low042000
Necrosis01986198638.0low010000
Necrotizing Pyelonephritis01985198539.0low010000
Pain01983198738.8low350000
Pancreatitis01985198539.0low010000
Parathyroid Neoplasms01983198738.7low030000
Parkinson Disease, Secondary01993199331.0low001000
Peritoneal Diseases01989198935.0low010000
Phlegmasia Alba Dolens01986198737.5low020000
Postoperative Complications01985198937.0low020000
Pregnancy01989199034.7low021000
Prostatic Neoplasms01977199734.0low012000
Pulmonary Edema01982198242.0low010000
Pulmonary Embolism01994199430.0low001000
Pulmonary Hypertension01983198838.5low020000
Pyelonephritis01985198539.0low010000
Renal Artery Obstruction01983198540.0low030000
Renal Artery Stenosis01983198540.0low030000
Renal Insufficiency01997199727.0low001000
Rhabdomyoma01984198440.0low010000
Rheumatic Heart Disease01983198341.0low010000
SC Disease01985198539.0low010000
Seizures01993199629.5low002000
Sensitivity and Specificity01997200025.5low102000
Sinus Infections01995199529.0low001000
Sinusitis01995199529.0low001000
Staphylococcal Infections01997199727.0low001000
Tachyarrhythmia01986198638.0low010000
Tachycardia01986198638.0low010000
Thoracic Neoplasms01984198440.0low010000
Thrombocytopenia01986198936.5low020000
Thrombopenia01986198936.5low020000
Thrombophlebitis01986198737.5low020000
Thrombosis01985198539.0low010000
Tracheal Diseases01984198440.0low010000
Urinary Bladder Neoplasms01977198939.0low030000
Vascular Diseases01982198441.0low020000
Ventricular Fibrillation01984199037.7low192000
Vomiting01995199529.0low001000

Safety/Toxicity (7)

ArticleYear
The SHR as a small animal model for radiocontrast renal failure. Relation of nephrotoxicity to animal's age, gender, strain, and dose of radiocontrast.
Renal failure, , Volume: 19, Issue:6
1997
Nephrotoxicity of contrast media assessed by occlusion arteriography.
Radiology, , Volume: 152, Issue:3
1984
A double-blind clinical study comparing the safety and efficacy of Hexabrix and Renografin-76 in contrast enhanced computed body tomography.
Investigative radiology, , Volume: 19, Issue:6 Suppl
A double-blind clinical study comparing tolerability, safety, and efficacy of Hexabrix and Renografin-76 for intravenous subtraction angiography.
Investigative radiology, , Volume: 19, Issue:6 Suppl
A double-blind clinical comparison of the electrophysiologic adverse effects of Hexabrix and Renografin-76.
Investigative radiology, , Volume: 19, Issue:6 Suppl
Myocardial contrast echocardiography in humans: I. Safety--a comparison with routine coronary arteriography.
Journal of the American College of Cardiology, , Volume: 8, Issue:5
1986
Safety of saline irrigation for angioscopy: results of a prospective randomized trial.
Annals of vascular surgery, , Volume: 6, Issue:1
1992

Pharmacokinetics (4)

ArticleYear
A comparison of peak-to-peak pulmonary transit time determined by digital intravenous angiography with standard dye-dilution techniques in anesthetized dogs.
Investigative radiology, , Volume: 17, Issue:4
Optimal injection technique for intravenous digital subtraction angiography. Animal and clinical studies of right atrial injection using small volumes (25 ml) at a high rate (35 ml/sec).
Radiology, , Volume: 150, Issue:3
1984
Renal clearance of an ionic high-osmolar and a nonionic low-osmolar contrast medium.
Investigative radiology, , Volume: 26, Issue:6
1991
Heparin pharmacokinetics and in vitro anticoagulant activity in patients receiving nonionic radiographic contrast media.
Cardiology, , Volume: 79, Issue:1
1991

Dosage (3)

ArticleYear
Computer enhanced digital angiography.
Clinical cardiology, , Volume: 5, Issue:5
1982
Double-blind comparison of Hexabrix and Renografin-76 in computed tomography.
Investigative radiology, , Volume: 19, Issue:6 Suppl
Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.
The American journal of medicine, , Volume: 86, Issue:6 Pt 1
1989